Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 13

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Topical Antibiofilm Agents With Potential Utility in the Treatment of Chronic Rhinosinusitis: A Narrative Review

Hale, Samuel J. M., Wagner Mackenzie, Brett, Lux, Christian A., Biswas, Kristi, Kim, Raymond, Douglas, Richard G. · 2022 · Frontiers in Pharmacology

Abstract

The role of bacterial biofilms in chronic and recalcitrant diseases is widely appreciated, and the treatment of biofilm infection is an increasingly important area of research. Chronic rhinosinusitis (CRS) is a complex disease associated with sinonasal dysbiosis and the presence of bacterial biofilms. While most biofilm-related diseases are associated with highly persistent but relatively less severe inflammation, the presence of biofilms in CRS is associated with greater severity of inflammation and recalcitrance despite appropriate treatment. Oral antibiotics are commonly used to treat CRS but they are often ineffective, due to poor penetration of the sinonasal mucosa and the inherently antibiotic resistant nature of bacteria in biofilms. Topical non-antibiotic antibiofilm agents may prove more effective, but few such agents are available for sinonasal application. We review compounds with antibiofilm activity that may be useful for treating biofilm-associated CRS, including halogen-based compounds, quaternary ammonium compounds and derivatives, biguanides, antimicrobial peptides, chelating agents and natural products. These include preparations that are currently available and those still in development. For each compound, antibiofilm efficacy, mechanism of action, and toxicity as it relates to sinonasal application are summarised. We highlight the antibiofilm agents that we believe hold the greatest promise for the treatment of biofilm-associated CRS in order to inform future research on the management of this difficult condition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2022.840323

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 125

  1. Akdis, 2021, Does the Epithelial Barrier Hypothesis Explain the Increase in Allergy, Autoimmunity and Other Chronic Conditions?, Nat. Rev. Immunol., 21, 739, 10.1038/s41577-021-00538-7 · DOI · Paper page
  2. Al-Bakri, 2009, The Assessment of the Antibacterial and Antifungal Activities of Aspirin, EDTA and Aspirin-EDTA Combination and Their Effectiveness as Antibiofilm Agents, J. Appl. Microbiol., 107, 280, 10.1111/j.1365-2672.2009.04205.x · DOI
  3. Alandejani, 2009, Effectiveness of Honey on Staphylococcus aureus and Pseudomonas aeruginosa Biofilms, Otolaryngol. Head Neck Surg., 141, 114, 10.1016/j.otohns.2009.01.005 · DOI · Paper page
  4. Ammons, 2013, Mini-review: Lactoferrin: a Bioinspired, Anti-biofilm Therapeutic, Biofouling, 29, 443, 10.1080/08927014.2013.773317 · DOI
  5. Banin, 2006, Chelator-induced Dispersal and Killing of Pseudomonas aeruginosa Cells in a Biofilm, Appl. Environ. Microbiol., 72, 2064, 10.1128/aem.72.3.2064-2069.2006 · DOI · Paper page
  6. Barreto, 2020, Addressing the Challenges in Antisepsis: Focus on Povidone Iodine, Int. J. Antimicrob. Agents, 56, 106064, 10.1016/j.ijantimicag.2020.106064 · DOI
  7. Berditsch, 2019, Supreme Activity of Gramicidin S against Resistant, Persistent and Biofilm Cells of Staphylococci and Enterococci, Sci. Rep., 9, 17938, 10.1038/s41598-019-54212-z · DOI
  8. Berditsch, 2015, Synergistic Effect of Membrane-Active Peptides Polymyxin B and Gramicidin S on Multidrug-Resistant Strains and Biofilms of Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 59, 5288, 10.1128/aac.00682-15 · DOI
  9. Bigliardi, 2017, Povidone Iodine in Wound Healing: a Review of Current Concepts and Practices, Int. J. Surg., 44, 260, 10.1016/j.ijsu.2017.06.073 · DOI · Paper page
  10. Birk, 2015, Polyhexanide-containing Solution Reduces Ciliary Beat Frequency of Human Nasal Epithelial Cells In Vitro, Eur. Arch. Otorhinolaryngol., 272, 377, 10.1007/s00405-014-3112-5 · DOI
  11. Blaskovich, 2021, The Antimicrobial Potential of Cannabidiol, Commun. Biol., 4, 7, 10.1038/s42003-020-01530-y · DOI · Paper page
  12. Bridier, 2011, Dynamics of the Action of Biocides in Pseudomonas aeruginosa Biofilms, Antimicrob. Agents Chemother., 55, 2648, 10.1128/aac.01760-10 · DOI
  13. Campanac, 2002, Interactions between Biocide Cationic Agents and Bacterial Biofilms, Antimicrob. Agents Chemother., 46, 1469, 10.1128/aac.46.5.1469-1474.2002 · DOI · Paper page
  14. Camplin, 2014, Manuka Honey Treatment of Biofilms of Pseudomonas aeruginosa Results in the Emergence of Isolates with Increased Honey Resistance, Ann. Clin. Microbiol. Antimicrob., 13, 19, 10.1186/1476-0711-13-19 · DOI
  15. Capriotti, 2018, Efficacy of Dilute Povidone-Iodine against Multi-Drug Resistant Bacterial Biofilms, Fungal Biofilms and Fungal Spores, Clin. Res. Dermatol. Open Access, 5, 1, 10.15226/2378-1726/5/1/00174 · DOI
  16. Cavaliere, 2014, The Biofilm Matrix Destabilizers, EDTA and DNaseI, Enhance the Susceptibility of Nontypeable Hemophilus Influenzae Biofilms to Treatment with Ampicillin and Ciprofloxacin, MicrobiologyOpen, 3, 557, 10.1002/mbo3.187 · DOI
  17. Chen, 2012, Bacterial Biofilms in Chronic Rhinosinusitis and Their Relationship with Inflammation Severity, Auris Nasus Larynx, 39, 169, 10.1016/j.anl.2011.04.014 · doi:10.1016/j.anl.2011.04.014
  18. Chennupati, 2009, Effects of an LL-37–Derived Antimicrobial Peptide in an Animal Model of Biofilm Pseudomonas Sinusitis, Am. J. Rhinol Allergy, 23, 46, 10.2500/ajra.2009.23.3261 · doi:10.2500/ajra.2009.23.3261
  19. Cherian, 2019, Effect of Commercial Nasal Steroid Preparation on Bacterial Growth, Int. Forum Allergy Rhinol, 9, 766, 10.1002/alr.22312 · doi:10.1002/alr.22312
  20. Chiu, 2008, Baby Shampoo Nasal Irrigations for the Symptomatic post–functional Endoscopic Sinus Surgery Patient, Am. J. Rhinol, 22, 34, 10.2500/ajr.2008.22.3122 · DOI · Paper page
  21. Cooper, 2007, Iodine Revisited, Int. Wound J., 4, 124, 10.1111/j.1742-481x.2007.00314.x · DOI
  22. Damour, 1992, Cytotoxicity Evaluation of Antiseptics and Antibiotics on Cultured Human Fibroblasts and Keratinocytes, Burns, 18, 479, 10.1016/0305-4179(92)90180-3 · DOI
  23. Daood, 2020, A Quaternary Ammonium Silane Antimicrobial Triggers Bacterial Membrane and Biofilm Destruction, Sci. Rep., 10, 10970, 10.1038/s41598-020-67616-z · DOI
  24. Dean, 2011, Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-Enantiomer of LL-37, Front. Microbiol., 2, 128, 10.3389/fmicb.2011.00128 · DOI · Paper page
  25. Drilling, 2014, Safety and Efficacy of Topical Bacteriophage and Ethylenediaminetetraacetic Acid Treatment of Staphylococcus aureus Infection in a Sheep Model of Sinusitis, Int. Forum Allergy Rhinol, 4, 176, 10.1002/alr.21270 · DOI
  26. Farha, 2020, Uncovering the Hidden Antibiotic Potential of Cannabis, ACS Infect. Dis., 6, 338, 10.1021/acsinfecdis.9b00419 · DOI
  27. Ferran, 2016, Comparison of the In Vitro Activity of Five Antimicrobial Drugs against Staphylococcus Pseudintermedius and Staphylococcus Aureus Biofilms, Front. Microbiol., 7, 1187, 10.3389/fmicb.2016.01187 · DOI
  28. Fokkens, 2020, European Position Paper on Rhinosinusitis and Nasal Polyps 2020, Rhinology Suppl., 29, 1, 10.4193/rhin20.600 · DOI · Paper page
  29. Fong, 2019, Safety and Efficacy of a Bacteriophage Cocktail in an In Vivo Model of Pseudomonas aeruginosa Sinusitis, Transl Res., 206, 41, 10.1016/j.trsl.2018.12.002 · DOI
  30. Fong, 2017, Activity of Bacteriophages in Removing Biofilms of Pseudomonas aeruginosa Isolates from Chronic Rhinosinusitis Patients, Front Cel Infect Microbiol, 7, 418, 10.3389/fcimb.2017.00418 · DOI · Paper page
  31. Foreman, 2011, Do biofilms Contribute to the Initiation and Recalcitrance of Chronic Rhinosinusitis?, Laryngoscope, 121, 1085, 10.1002/lary.21438 · DOI
  32. Gaurav, 2020, Assessment of Polymyxin B–Doxycycline in Combination against Pseudomonas aeruginosa In Vitro and in a Mouse Model of Acute Pneumonia, Int. J. Antimicrob. Agents, 56, 106022, 10.1016/j.ijantimicag.2020.106022 · DOI
  33. Gawande, 2014, Antibiofilm Efficacy of DispersinB® Wound spray Used in Combination with a Silver Wound Dressing, Microbiol. Insights, 7, 9, 10.4137/mbi.s13914 · DOI
  34. Gilbert, 2005, Cationic Antiseptics: Diversity of Action under a Common Epithet, J. Appl. Microbiol., 99, 703, 10.1111/j.1365-2672.2005.02664.x · DOI · Paper page
  35. Graziano, 2015, Statins and Antimicrobial Effects: Simvastatin as a Potential Drug against Staphylococcus aureus Biofilm, PLoS ONE, 10, e0128098, 10.1371/journal.pone.0128098 · DOI
  36. Günther, 2021, Ability of Chlorhexidine, Octenidine, Polyhexanide and Chloroxylenol to Inhibit Metabolism of Biofilm-Forming Clinical Multidrug-Resistant Organisms, J. Infect. Prev., 22, 12, 10.1177/1757177420963829 · DOI
  37. Hardcastle, 2017, The In Vitro Mucolytic Effect of Xylitol and Dornase Alfa on Chronic Rhinosinusitis Mucus, Int. Forum Allergy Rhinol, 7, 889, 10.1002/alr.21970 · DOI
  38. Harrison, 2008, Copper and Quaternary Ammonium Cations Exert Synergistic Bactericidal and Antibiofilm Activity against Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 52, 2870, 10.1128/aac.00203-08 · DOI · Paper page
  39. Heir, 1999, The qacG Gene on Plasmid pST94 Confers Resistance to Quaternary Ammonium Compounds in Staphylococci Isolated from the Food Industry, J. Appl. Microbiol., 86, 378, 10.1046/j.1365-2672.1999.00672.x · DOI
  40. Herrera, 2019, First Report of Polymyxin B Activity in Klebsiella pneumoniae Biofilm, J. Chemother., 31, 127, 10.1080/1120009x.2018.1558751 · DOI
  41. Herruzo, 2020, Antimicrobial Efficacy of a Very Stable Hypochlorous Acid Formula Compared with Other Antiseptics Used in Treating Wounds: In-Vitro Study on Micro-organisms with or without Biofilm, J. Hosp. Infect., 105, 289, 10.1016/j.jhin.2020.01.013 · DOI
  42. Hill, 2000, The In-Vitro Activity of Povidone–Iodine Cream against Staphylococcus aureus and its Bioavailability in Nasal Secretions, J. Hosp. Infect., 45, 198, 10.1053/jhin.2000.0733 · DOI
  43. Hoekstra, 2017, Povidone‐iodine Ointment Demonstrates In Vitro Efficacy against Biofilm Formation, Int. Wound J., 14, 172, 10.1111/iwj.12578 · DOI
  44. Hogan, 2016, In Vitro approach for Identification of the Most Effective Agents for Antimicrobial Lock Therapy in the Treatment of Intravascular Catheter-Related Infections Caused by Staphylococcus aureus, Antimicrob. Agents Chemother., 60, 2923, 10.1128/aac.02885-15 · DOI
  45. Hoggard, Evidence of Microbiota Dysbiosis in Chronic Rhinosinusitis, Int. Forum Allergy Rhinol, 7, 230, 10.1002/alr.21871 · DOI · Paper page
  46. Hoggard, Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease, Clin. Microbiol. Rev., 30, 321, 10.1128/cmr.00060-16 · DOI
  47. Hoggard, 2019, The Sinonasal Mycobiota in Chronic Rhinosinusitis and Control Patients, Rhinology, 57, 190, 10.4193/rhin18.256 · DOI
  48. Horner, 2012, Reduced Susceptibility to Chlorhexidine in Staphylococci: Is it Increasing and Does it Matter?, J. Antimicrob. Chemother., 67, 2547, 10.1093/jac/dks284 · DOI · Paper page
  49. Isaacs, 2011, The Effect of Dilute Baby Shampoo on Nasal Mucociliary Clearance in Healthy Subjects, Am. J. Rhinol Allergy, 25, e27, 10.2500/ajra.2011.25.3583 · DOI
  50. Jain, 2015, The Effects of Topical Agents on Paranasal Sinus Mucosa Healing: a Rabbit Study, Int. Forum Allergy Rhinol, 5, 310, 10.1002/alr.21470 · DOI
  51. Jain, 2016, The In Vitro Effect of Xylitol on Chronic Rhinosinusitis Biofilms, Rhinology, 54, 323, 10.4193/rhin15.380 · doi:10.4193/rhin15.380
  52. Jennings, 2014, Biofilm‐eradicating Properties of Quaternary Ammonium Amphiphiles: Simple Mimics of Antimicrobial Peptides, ChemBioChem, 15, 2211, 10.1002/cbic.201402254 · DOI
  53. Jeronimo, 2020, Effects of Povidone‐iodine Composite on the Elimination of Bacterial Biofilm, Int. Forum Allergy Rhinol, 10, 884, 10.1002/alr.22568 · doi:10.1002/alr.22568
  54. Jervis‐Bardy, 2011, Methylglyoxal‐infused Honey Mimics the Anti‐ Staphylococcus aureus Biofilm Activity of Manuka Honey: Potential Implication in Chronic Rhinosinusitis, Laryngoscope, 121, 1104, 10.1002/lary.21717 · DOI
  55. Johani, 2018, Evaluation of Short Exposure Times of Antimicrobial Wound Solutions against Microbial Biofilms: from In Vitro to In Vivo, J. Antimicrob. Chemother., 73, 494, 10.1093/jac/dkx391 · DOI
  56. Jorge, 2017, Searching for New Strategies against Biofilm Infections: Colistin-AMP Combinations against Pseudomonas aeruginosa and Staphylococcus aureus Single- and Double-Species Biofilms, PLoS ONE, 12, e0174654, 10.1371/journal.pone.0174654 · DOI
  57. Kamaruzzaman, 2017, Bactericidal and Anti-biofilm Effects of Polyhexamethylene Biguanide in Models of Intracellular and Biofilm of Staphylococcus aureus Isolated from Bovine Mastitis, Front. Microbiol., 8, 1518, 10.3389/fmicb.2017.01518 · DOI
  58. Kang, 2019, Antimicrobial Peptide LL-37 Is Bactericidal against Staphylococcus aureus Biofilms, PLoS ONE, 14, e0216676, 10.1371/journal.pone.0216676 · DOI
  59. Karas, 2020, The Antimicrobial Activity of Cannabinoids, Antibiotics, 9, 406, 10.3390/antibiotics9070406 · DOI
  60. Khondker, 2020, How Do Bacterial Membranes Resist Polymyxin Antibiotics?, Commun. Biol., 3, 77, 10.1038/s42003-020-0803-x · DOI
  61. Kilty, 2010, Manuka Honey: Histological Effect on Respiratory Mucosa, Am. J. Rhinol Allergy, 24, e63, 10.2500/ajra.2010.24.345310.2500/194589210791496519 · doi:10.2500/ajra.2010.24.345310.2500/194589210791496519
  62. Kilty, 2011, Methylglyoxal: (Active Agent of Manuka Honey) In Vitro Activity against Bacterial Biofilms, Int. Forum Allergy Rhinol, 1, 348, 10.1002/alr.20073 · DOI
  63. Kim, 2015, Betadine Has a Ciliotoxic Effect on Ciliated Human Respiratory Cells, J. Laryngol. Otol, 129, S45, 10.1017/s0022215114002746 · doi:10.1017/s0022215114002746
  64. Klinger-Strobel, 2017, Effects of Colistin on Biofilm Matrices of Escherichia coli and Staphylococcus aureus, Int. J. Antimicrob. Agents, 49, 472, 10.1016/j.ijantimicag.2017.01.005 · DOI
  65. Ko, 2018, In Vitro antibacterial Effects of Statins against Bacterial Pathogens Causing Skin Infections, Eur. J. Clin. Microbiol. Infect. Dis., 37, 1125, 10.1007/s10096-018-3227-5 · DOI
  66. Kolpen, 2016, Increased Bactericidal Activity of Colistin on Pseudomonas aeruginosa Biofilms in Anaerobic Conditions, Pathog. Dis., 74, ftv086, 10.1093/femspd/ftv086 · DOI
  67. Krasowski, 2021, In Vitro evaluation of Polihexanide, Octenidine and NaClO/HClO-Based Antiseptics against Biofilm Formed by Wound Pathogens, Membranes, 11, 62, 10.3390/membranes11010062 · DOI
  68. Lee, 2017, Manuka Honey Sinus Irrigation for the Treatment of Chronic Rhinosinusitis: a Randomized Controlled Trial, Int. Forum Allergy Rhinol, 7, 365, 10.1002/alr.21898 · DOI
  69. Lefebvre, 2016, Synergistic Antibiofilm Efficacy of Various Commercial Antiseptics, Enzymes and EDTA: a Study of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms, Int. J. Antimicrob. Agents, 48, 181, 10.1016/j.ijantimicag.2016.05.008 · DOI
  70. Lima, 2019, Evaluation of the Interaction between Polymyxin B and Pseudomonas aeruginosa Biofilm and Planktonic Cells: Reactive Oxygen Species Induction and Zeta Potential, BMC Microbiol., 19, 115, 10.1186/s12866-019-1485-8 · DOI
  71. Lin, 2017, Xylitol Nasal Irrigation in the Treatment of Chronic Rhinosinusitis, Am. J. Otolaryngol., 38, 383, 10.1016/j.amjoto.2017.03.006 · DOI
  72. Liu, 2018, Tetrasodium EDTA Is Effective at Eradicating Biolms Formed by Clinically Relevant Microorganisms from Patients’ central Venous Catheters, mSphere, 3, e00525, 10.1128/msphere.00525-18 · DOI
  73. Liu, 2017, In Vitro and In Vivo Activity of EDTA and Antibacterial Agents against the Biofilm of Mucoid Pseudomonas aeruginosa, Infection, 45, 23, 10.1007/s15010-016-0905-z · DOI
  74. Lux, 2022, The In Vitro Efficacy of Neutral Electrolysed Water and Povidone-Iodine against CRS-Associated Biofilms, Rhinology, 60, 73, 10.4193/rhin21.301 · DOI
  75. Machuca, 2019, Comparative Activity of a Polyhexanide–Betaine Solution against Biofilms Produced by Multidrug-Resistant Bacteria Belonging to High-Risk Clones, J. Hosp. Infect., 103, e92, 10.1016/j.jhin.2019.04.008 · doi:10.1016/j.jhin.2019.04.008
  76. Mills, 1956, Staphylococcus Bacteriophage Lysate Aerosol Therapy of Sinusitis, Laryngoscope, 66, 846, 10.1288/00005537-195607000-00004 · doi:10.1288/00005537-195607000-00004
  77. Müller, 2008, Biocompatibility index of Antiseptic Agents by Parallel Assessment of Antimicrobial Activity and Cellular Cytotoxicity, J. Antimicrob. Chemother., 61, 1281, 10.1093/jac/dkn125 · DOI · Paper page
  78. Ooi, Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus, JAMA Otolaryngol. Head Neck Surg., 145, 723, 10.1001/jamaoto.2019.1191 · DOI · Paper page
  79. Ooi, Manuka Honey Sinus Irrigations in Recalcitrant Chronic Rhinosinusitis: Phase 1 Randomized, Single‐blinded, Placebo‐controlled Trial, Int. Forum Allergy Rhinol, 9, 1470, 10.1002/alr.22423 · doi:10.1002/alr.22423
  80. Ooi, Topical Colloidal Silver for the Treatment of Recalcitrant Chronic Rhinosinusitis, Front. Microbiol., 9, 720, 10.3389/fmicb.2018.00720 · DOI · Paper page
  81. Ooi, Safety and Efficacy of Topical Chitogel- Deferiprone-Gallium Protoporphyrin in Sheep Model, Front. Microbiol., 9, 917, 10.3389/fmicb.2018.00917 · DOI
  82. Orlandi, 2021, International Consensus Statement on Allergy and Rhinology: Rhinosinusitis 2021, Int. Forum Allergy Rhinol, 11, 213, 10.1002/alr.22741 · DOI · Paper page
  83. Panchmatia, 2019, The Efficacy of Diluted Topical Povidone-Iodine Rinses in the Management of Recalcitrant Chronic Rhinosinusitis: a Prospective Cohort Study, Eur. Arch. Otorhinolaryngol., 276, 3373, 10.1007/s00405-019-05628-w · DOI
  84. Papa, 2020, Safety and Tolerability of Topical Polyhexamethylene Biguanide: a Randomised Clinical Trial in Healthy Adult Volunteers, Br. J. Ophthalmol., 106, 190, 10.1136/bjophthalmol-2020-317848 · doi:10.1136/bjophthalmol-2020-317848
  85. Paramasivan, 2014, Methylglyoxal‐augmented Manuka Honey as a Topical Anti– Staphylococcus aureus Biofilm Agent: Safety and Efficacy in an In Vivo Model, Int. Forum Allergy Rhinol, 4, 187, 10.1002/alr.21264 · DOI
  86. Percival, 2017, The Efficacy of Tetrasodium EDTA on Biofilms, 101
  87. Premkumar, 2021, Comparing the Efficacy of Irrigation Solutions on Staphylococcal Biofilm Formed on Arthroplasty Surfaces, J. Arthroplasty, 36, S26, 10.1016/j.arth.2021.02.033 · doi:10.1016/j.arth.2021.02.033
  88. Psaltis, 2008, Reduced Levels of Lactoferrin in Biofilm-Associated Chronic Rhinosinusitis, Laryngoscope, 118, 895, 10.1097/mlg.0b013e31816381d4 · DOI
  89. Ramamourthy, 2021, Antibiofilm Activity of Lactoferrin-Derived Synthetic Peptides against Pseudomonas aeruginosa PAO1, Biochem. Cel Biol, 99, 138, 10.1139/bcb-2020-0253 · DOI
  90. Ramezanpour, 2020, In Vitro safety Evaluation of a Povidone‐iodine Solution Applied to Human Nasal Epithelial Cells, Int. Forum Allergy Rhinol, 10, 1141, 10.1002/alr.22575 · DOI
  91. Reimer, 2002, Antimicrobial Effectiveness of Povidone-Iodine and Consequences for New Application Areas, Dermatology, 204, 114, 10.1159/000057738 · doi:10.1159/000057738
  92. Richter, Taking the Silver Bullet Colloidal Silver Particles for the Topical Treatment of Biofilm-Related Infections, ACS Appl. Mater. Inter., 9, 21631, 10.1021/acsami.7b03672 · DOI
  93. Richter, 2016, Mind “De GaPP”: In Vitro Efficacy of Deferiprone and Gallium‐protoporphyrin against Staphylococcus aureus Biofilms, Int. Forum Allergy Rhinol, 6, 737, 10.1002/alr.21735 · DOI
  94. Richter, A Topical Hydrogel with Deferiprone and Gallium-Protoporphyrin Targets Bacterial Iron Metabolism and Has Antibiofilm Activity, Antimicrob. Agents Chemother., 61, e00481, 10.1128/aac.00481-17 · DOI
  95. Riechelmann, 2004, Nasal Toxicity of Benzalkonium Chloride, Am. J. Rhinol, 18, 291, 10.1177/194589240401800506 · DOI
  96. Röhner, 2020, Sodium Hypochlorite Is More Effective Than Chlorhexidine for Eradication of Bacterial Biofilm of Staphylococci and Pseudomonas aeruginosa, Knee Surg. Sports Traumatol. Arthrosc., 28, 3912, 10.1007/s00167-020-05887-9 · DOI
  97. Roy, 2018, Strategies for Combating Bacterial Biofilms: a Focus on Anti-biofilm Agents and Their Mechanisms of Action, Virulence, 9, 522, 10.1080/21505594.2017.1313372 · DOI · Paper page
  98. Rudilla, 2018, Novel Synthetic Polymyxins Kill Gram-Positive Bacteria, J. Antimicrob. Chemother., 73, 3385, 10.1093/jac/dky366 · doi:10.1093/jac/dky366
  99. Sahariah, 2018, Quaternary Ammoniumyl Chitosan Derivatives for Eradication of Staphylococcus aureus Biofilms, Biomacromolecules, 19, 3649, 10.1021/acs.biomac.8b00718 · doi:10.1021/acs.biomac.8b00718
  100. Scheper, 2021, SAAP-148 Eradicates MRSA Persisters within Mature Biofilm Models Simulating Prosthetic Joint Infection, Front. Microbiol., 12, 625952, 10.3389/fmicb.2021.625952 · DOI
  101. Schreier, 1997, Molecular Effects of Povidone-Iodine on Relevant Microorganisms: an Electron-Microscopic and Biochemical Study, Dermatology, 195, 111, 10.1159/000246043 · doi:10.1159/000246043
  102. Shelanski, 1956, PVP-iodine: History, Toxicity and Therapeutic Uses, J. Int. Coll. Surg., 25, 727
  103. Singhal, 2011, Staphylococcus aureus Biofilms: Nemesis of Endoscopic Sinus Surgery, Laryngoscope, 121, 1578, 10.1002/lary.21805 · DOI
  104. Siu, 2020, Oral Antibiotics Used in the Treatment of Chronic Rhinosinusitis Have Limited Penetration into the Sinonasal Mucosa: a Randomized Trial, Xenobiotica, 50, 1443, 10.1080/00498254.2020.1814973 · DOI · Paper page
  105. Sivaranjani, 2021, Synergistic Activity of Tetrasodium EDTA, Ethanol and Chlorhexidine Hydrochloride against Planktonic and Biofilm Cells of Clinically Relevant Pathogens, J. Glob. Antimicrob. Resist., 24, 148, 10.1016/j.jgar.2020.12.002 · DOI
  106. Stewart, 2001, Antibiotic Resistance of Bacteria in Biofilms, Lancet, 358, 135, 10.1016/s0140-6736(01)05321-1 · DOI · Paper page
  107. Su, 2019, Polymyxin Derivatives as Broad-Spectrum Antibiotic Agents, Chem. Commun., 55, 13104, 10.1039/c9cc06908a · doi:10.1039/c9cc06908a
  108. Sultan, 2017, Chelation Therapy in Cardiovascular Disease: an Update, Expert Rev. Clin. Pharmacol., 10, 843, 10.1080/17512433.2017.1339601 · DOI
  109. Taylor, 2021, Non-steroid, Non-antibiotic Anti-biofilm Therapy for the Treatment of Chronic Rhinosinusitis: a Systematic Review, J. Laryngol. Otol, 135, 196, 10.1017/s0022215121000542 · DOI
  110. Thangamani, 2015, Exploring Simvastatin, an Antihyperlipidemic Drug, as a Potential Topical Antibacterial Agent, Sci. Rep., 5, 16407, 10.1038/srep16407 · DOI
  111. Thieme, 2019, MBEC versus MBIC: the Lack of Differentiation between Biofilm Reducing and Inhibitory Effects as a Current Problem in Biofilm Methodology, Biol. Proced. Online, 21, 18, 10.1186/s12575-019-0106-0 · DOI
  112. Thorn, 2012, Electrochemically Activated Solutions: Evidence for Antimicrobial Efficacy and Applications in Healthcare Environments, Eur. J. Clin. Microbiol. Infect. Dis., 31, 641, 10.1007/s10096-011-1369-9 · DOI
  113. Turner, 2017, Safety and Tolerability of Surfactant Nasal Irrigation, Int. Forum Allergy Rhinol, 7, 809, 10.1002/alr.21959 · doi:10.1002/alr.21959
  114. Valentine, 2011, Efficacy of Using a Hydrodebrider and of Citric Acid/zwitterionic Surfactant on a Staphylococcus aureus Bacterial Biofilm in the Sheep Model of Rhinosinusitis, Am. J. Rhinol Allergy, 25, 323, 10.2500/ajra.2011.25.3659 · DOI
  115. van de Donk, 1980, The Effects of Preservatives on the Ciliary Beat Frequency of Chicken Embryo Tracheas, Rhinology, 18, 119
  116. van Klingeren, 1976, Antibacterial Activity of Δ9-tetrahydrocannabinol and Cannabidiol, Antonie van Leeuwenhoek, 42, 9, 10.1007/BF00399444 · DOI
  117. Verderosa, 2019, Bacterial Biofilm Eradication Agents: a Current Review, Front. Chem., 7, 824, 10.3389/fchem.2019.00824 · DOI · Paper page
  118. Vickery, 2019, The Role of Staphylococcus aureus in Patients with Chronic Sinusitis and Nasal Polyposis, Curr. Allergy Asthma Rep., 19, 21, 10.1007/s11882-019-0853-7 · DOI
  119. Wagner Mackenzie, 2017, Bacterial Community Collapse: a Meta‐analysis of the Sinonasal Microbiota in Chronic Rhinosinusitis, Environ. Microbiol., 19, 381, 10.1111/1462-2920.13632 · DOI · Paper page
  120. Wagner Mackenzie, 2020, A Novel Description of the Human Sinus Archaeome during Health and Chronic Rhinosinusitis, Front. Cel Infect Microbiol, 10, 398, 10.3389/fcimb.2020.00398 · DOI
  121. Weissman, 2011, Xylitol Nasal Irrigation in the Management of Chronic Rhinosinusitis: a Pilot Study, Laryngoscope, 121, 2468, 10.1002/lary.22176 · DOI
  122. Wu, 2021, Efficacy of Povidone‐iodine Nasal Irrigation Solution after Sinonasal Surgery: a Randomized Controlled Study, Laryngoscope, 1, 1, 10.1002/lary.29818 · DOI
  123. Yin, 2020, Mechanisms of Bactericidal Action and Resistance of Polymyxins for Gram-Positive Bacteria, Appl. Microbiol. Biotechnol., 104, 3771, 10.1007/s00253-020-10525-y · DOI
  124. Yoshida, 1993, Potent In Vitro Bactericidal Activity of Polymyxin B against Methicillin‐resistant Staphylococcus aureus (MRSA), Microbiol. Immunol., 37, 853, 10.1111/j.1348-0421.1993.tb01716.x · DOI
  125. Zheng, 2021, Effect of Polyhexamethylene Biguanide in Combination with Undecylenamidopropyl Betaine or PslG on Biofilm Clearance, Int. J. Mol. Sci., 22, 768, 10.3390/ijms22020768 · DOI

Cited by

Metadata

Authors
Hale, S. J. M., Wagner Mackenzie, B., Lux, C. A., Biswas, K., Kim, R., & Douglas, R. G.
Venue
Frontiers in Pharmacology
Published
2022-06-13
Volume
13
ISSN
1663-9812
Cited by
13
References
1
Funders
  • Garnett Passe and Rodney Williams Memorial Foundation (3719672 3723406)
  • Auckland Medical Research Foundation (3721397)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.